| Jane R Schwebke, MD | |
|
619 19th Street South, Birmingham, AL 35233 | |
| (205) 934-6600 | |
| Not Available |
| Full Name | Jane R Schwebke |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Infectious Disease |
| Location | 619 19th Street South, Birmingham, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124040225 | NPI | - | NPPES |
| 051510712 | Other | AL | BLUE CROSS |
| 051517789 | Other | AL | BLUE CROSS |
| 000024709 | Medicaid | AL | |
| 009930715 | Medicaid | AL | |
| 000024709 | Other | AL | BLUE CROSS |
| 009905375 | Medicaid | AL | |
| 440001211 | Other | AL | RAILROAD MEDICARE |
| E85065 | Other | AL | VIVA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 18396 (Alabama) | Primary |
| Entity Name | University Of Alabama Health Services Foundation, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
Life Technologies Corporation and the Ignite Institute for Individualized Health announced today a collaboration to create a ground-breaking genomic sequencing center at Ignite's new facility in Northern Virginia.
A new study finds a wide range of epigenetic changes-alterations in DNA across the genome that may be related to key environmental exposures-in children with Crohn's disease (CD), reports Inflammatory Bowel Diseases, official journal of the Crohn's & Colitis Foundation of America.
Newsweek examines the genetic modification of mosquitoes in an effort to stem the spread of dengue fever and malaria. Dengue fever, which is transmitted by the Aedes Aegypti mosquito, "is spreading fast," according to the magazine, with more than 100 million people afflicted yearly. "There is no vaccine, no cure and no solution," it reports.
At an online European Parliament workshop hosted by Sirpa Pietikäinen, MEP (Finland), Alzheimer Europe launched a new report "Dementia as a European Priority - A Policy Overview" which takes stock of dementia policy at an EU level and sets out recommendations for future priorities across Europe.
The Aeras Global TB Vaccine Foundation is pleased to announce receipt of a grant from the United States Food and Drug Administration (FDA) to develop new biological and immunological biomarkers for TB vaccine development. The FDA grant, which supports the coordination of a multi-investigator project with researchers from the United States, the United Kingdom and South Africa, will provide $362,102 in the first year of funding.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jane R Schwebke, MD Po Box 55310, Birmingham, AL 35255-5310 Ph: (205) 731-9701 | Jane R Schwebke, MD 619 19th Street South, Birmingham, AL 35233 Ph: (205) 934-6600 |
News Archive
Life Technologies Corporation and the Ignite Institute for Individualized Health announced today a collaboration to create a ground-breaking genomic sequencing center at Ignite's new facility in Northern Virginia.
A new study finds a wide range of epigenetic changes-alterations in DNA across the genome that may be related to key environmental exposures-in children with Crohn's disease (CD), reports Inflammatory Bowel Diseases, official journal of the Crohn's & Colitis Foundation of America.
Newsweek examines the genetic modification of mosquitoes in an effort to stem the spread of dengue fever and malaria. Dengue fever, which is transmitted by the Aedes Aegypti mosquito, "is spreading fast," according to the magazine, with more than 100 million people afflicted yearly. "There is no vaccine, no cure and no solution," it reports.
At an online European Parliament workshop hosted by Sirpa Pietikäinen, MEP (Finland), Alzheimer Europe launched a new report "Dementia as a European Priority - A Policy Overview" which takes stock of dementia policy at an EU level and sets out recommendations for future priorities across Europe.
The Aeras Global TB Vaccine Foundation is pleased to announce receipt of a grant from the United States Food and Drug Administration (FDA) to develop new biological and immunological biomarkers for TB vaccine development. The FDA grant, which supports the coordination of a multi-investigator project with researchers from the United States, the United Kingdom and South Africa, will provide $362,102 in the first year of funding.
› Verified 3 days ago
Juan Mario Bernal, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3680 Grandview Pkwy Ste 200, Birmingham, AL 35243 Phone: 205-971-7500 | |
Dr. William Randolph Maddox, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 701 Princeton Ave Sw, Birmingham, AL 35211 Phone: 205-783-3000 Fax: 205-297-9411 | |
Jodie Ann Dionne, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 703 19th St S Bldg 206, Birmingham, AL 35233 Phone: 205-975-6530 | |
Dr. Karl Tullio Schroeder, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 817 Princeton Ave Sw Ste 199, Birmingham, AL 35211 Phone: 205-780-1920 Fax: 205-780-2345 | |
Dr. Deepti Bahl, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2000 6th Ave S, Birmingham, AL 35233 Phone: 205-934-9999 | |
Amitkumar Mehta, Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1720 2nd Ave S # Np2540t, Birmingham, AL 35294 Phone: 205-996-8400 Fax: 205-934-1608 | |
Shana Monika Machado, D.O. Infectious Disease Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011 |